
jan pm et
summari compani develop manufactur market medic equip treatment
diagnosi sleep-disord breath sdb
nm price-to-earnings oper ep
risk assess reflect view highli
competit natur respiratori market includ
low barrier entri see potenti
addit price pressur product due
fiscal year end jun ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan pm stock trade
follow sale growth fy jun
forecast revenu rise fy
fy new product thu
increas public awar
sleep-disord breath sdb major
health problem addit contribut
brightre acquisit market
share gain partli off-set increas
moder currenc headwind new
product includ comfort high-end
mask flow gener track patient
complianc next-gener ventil
america region continu show strong
emea apac region
gross margin like
fy fy compar
report fy see margin
improv stem product mix
shift toward softwar sale addit
improv manufactur synergi
brightre off-set declin averag
estim oper ep fy
fy fy
hold recommend reflect
view share trade full valu given
growth outlook despit challeng
price environ report
strong growth region fy
increas volum acceler adopt
solut ecosystem product
demand sdb market solid think
price mostli stabil
second round competit bid
medicar moreov like resist
sharp discount still expect price
product competit though
improv european asian
market driven volum growth new
product offer expans
emerg market india china
risk recommend target price
product recal product liabil
target price reflect
multipl fy ep estim
multipl slight premium peer
compar ten-year histor averag
price-to-earnings reflect improv sale
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
resm inc engag develop manufactur distribut medic equip
treat diagnos manag sleep-disord breath sdb respiratori disord
compani portfolio product treatment obstruct sleep apnea osa form
sdb includ airflow gener diagnost product mask system headgear accessori
produc continu posit airway pressur cpap variabl posit airway pressur vpap
autoset system titrat treatment sdb flow gener system deliv posit airway
pressur patient interfac either small nasal mask nasal pillow system full-fac mask
compani vpap unit deliv bi-level therapi market sleep record diagnosi
treatment sdb sleep clinic hospit
cpap vpap bi-level air flow gener account approxim fy jun total
revenu mask accessori motor diagnost product account recent
acquir brightre account remain
compani diagnost system record relev respiratori sleep data analyz
sleep specialist physician modifi appropri osa treatment regimen patient
assist profession diagnos manag treatment patient data
commun control product reslink rescontrol rescontrol ii txcontrol resscan
restraxx modul facilit transfer data inform flow
gener compani market variou product accessori includ humidifi
humidair connect directli cpap vpap autoset flow gener
humidifi heat air deliv patient option accessori includ cold passov
humidifi carri bag breath circuit
offer product north america latin america wholly-own subsidiari austria
finland franc germani spain sweden norway netherland switzerland unit kingdom
also wholli own subsidiari australia hong kong japan new zealand singapor china
india product market countri sleep clinic home health care dealer
compani competitor includ philip bv devilbiss divis sunris medic inc nellcor puritan
bennett divis covidien ltd fisher paykel healthcar corpor limit princip
intern competitor philip devilbiss nellcor puritan bennett addit product
compet surgic procedur dental applianc design treat osa- sdb-relat
see growth sdb market futur attribut posit number
factor includ increas awar osa improv understand role sdb treatment
manag cardiac neurolog metabol relat disord increas home-bas
diagnosi strategi busi oper develop toward effort capit
plan sdb market growth includ follow critic compon continu product
develop innov expans geograph presenc increas public clinic
awar expans new clinic applic leverag experi manag
fy spent million approxim net revenu million
fy compani seek new applic technolog current focu area
hypertens stroke congest heart failur chf chronic obstruct pulmonari diseas copd
develop devic treat cheyne-stok breath patient chf
presid saa
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
bullish sinc octob technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
capit budget amid shift
procedur inpati outpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
sub-index increas vs rise
 composit index follow
rise health equip
index vs declin
composit index year date
juli health
equip index rose vs rise
 composit index
fundament outlook health care
equip sub-industri next month
neutral continu view mani product
categori histor recession-resist
expect continu grow albeit
slowli growth procedur rate
slow area normal view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped recent howev equip
maker think certain procedur rate may
stabil start recov
medic devic tax requir
healthcar reform law went effect
januari temporarili
suspend
elect donald trump republican
retain control congress believ
gop abil substanti alter
afford act includ potenti
elimin variou health care sector fee
tax although gop replac
remain uncertain believ
potenti fewer insur patient
neg impact equip sub-industri
fewer insur patient would like lead
fewer procedur anticip
hospit largest buyer
medic equip would also advers
impact could pressur
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
demand certain product categori
unfavor foreign exchang continu
hospit becom cautiou regard
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
fy jun ep estim multipl slight premium peer given
organ acquisit driven sale growth outlook trim fy fy
ep estim report sep-q
oper ep vs capit iq consensu sep-q sale
increas driven growth america region strong devic
result expect revenu growth fy addit contribut
brightre acquisit market share gain /k snyder
hold buy rais target
fy jun ep estim multipl line peer
balanc sale growth outlook margin pressur cut fy ep
estim set fy estim
report jun-q oper ep vs capit iq
consensu jun-q sale increas growth america region
driven brightre acquisit growth mask accessori
expect sale growth fy driven market share gain growth
emea apac region /k snyder
analyst research note compani news
rais target fy june
ep estim compar ten-year histor averag price-to-earnings
modest premium peer reflect improv sale earn growth
outlook increas fy fy ep estim
report dec-q oper ep vs
consensu dec-q sale increas growth
canada latam market strong adopt product
sale growth fy aid new product /keith snyder
announc elect accomplish healthcar execut karen
drexler board director addit dr chri robert retir
serv compani board year ms drexler
appoint dr robert retir took effect follow
compani annual meet sharehold held nov afternoon
current serv ceo board member sandston diagnost
et cfra maintain hold opinion share inc
rais target price fy
june ep estim multipl slight discount peer
reflect slower organ sale growth outlook expect limit
margin expans rais fy ep estim
report sep-q oper ep vs line consensu
sep-q sale increas growth emea america
region well contribut brightre acquisit see
sale growth fy aid strong demand new mask /keith snyder
et cfra maintain hold opinion share inc
rais target price fy
jun ep estim multipl slight premium ten-year
histor averag price-to-earnings reflect improv long-term sale
earn growth outlook trim fy ep estim
set fy report jun-q oper ep vs
consensu jun-q sale increas driven growth
american devic sale growth emea/asia pacif devic sale
expect sale growth fy aid addit acquisit /k
et cfra maintain hold opinion share inc
keep target fy jun ep
estim line five-year histor averag price-to-earnings reflect
stabl sale growth outlook expect modest margin expans
product improv contribut brightre rais fy
fy ep estim
report mar-q oper ep vs consensu
mar-q sale increas exclud brightre growth emea
apac region see sale growth fy aid new product /k
et capit iq maintain hold opinion share
inc keep target
fy jun ep estim multipl slight premium peer
reflect sale growth outlook rais fy ep estim
cut fy report dec-q oper
ep vs capit iq consensu sale increas
aid contribut brightre acquisit strong result
america region see sale growth fy moder margin
expans driven product mix shift addit synergi brightre
inc maintain target price
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
